DBV Technologies SA (DBVT)
0.6651
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
0.665
0.00 (0.00%)
Pre-Market: 20:00
DBV Technologies Shareholders Equity (Quarterly): 140.19M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 140.19M |
| September 30, 2023 | 143.99M |
| June 30, 2023 | 164.24M |
| March 31, 2023 | 179.10M |
| December 31, 2022 | 194.45M |
| September 30, 2022 | 212.05M |
| June 30, 2022 | 244.42M |
| March 31, 2022 | 82.06M |
| December 31, 2021 | 99.28M |
| September 30, 2021 | 116.89M |
| June 30, 2021 | 143.02M |
| March 31, 2021 | 169.18M |
| December 31, 2020 | 205.49M |
| June 30, 2020 | 252.21M |
| December 31, 2019 | 193.19M |
| September 30, 2019 | 93.92M |
| June 30, 2019 | 132.26M |
| June 30, 2019 | 132.26M |
| December 31, 2018 | 138.74M |
| June 30, 2018 | 236.93M |
| Date | Value |
|---|---|
| June 30, 2018 | 236.93M |
| December 31, 2017 | 155.87M |
| June 30, 2017 | 219.27M |
| June 30, 2017 | 219.27M |
| December 31, 2016 | 255.40M |
| June 30, 2016 | 323.12M |
| June 30, 2016 | 323.12M |
| December 31, 2015 | 352.13M |
| June 30, 2015 | 118.48M |
| June 30, 2015 | 118.48M |
| December 31, 2014 | 140.38M |
| June 30, 2014 | 43.05M |
| June 30, 2014 | 43.05M |
| December 31, 2013 | 55.78M |
| June 30, 2013 | 43.54M |
| June 30, 2013 | 43.54M |
| December 31, 2012 | 51.81M |
| June 30, 2012 | 56.74M |
| December 31, 2011 | 15.17M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
82.06M
Minimum
Mar 2022
252.21M
Maximum
Jun 2020
161.01M
Average
154.12M
Median
Shareholders Equity (Quarterly) Benchmarks
| Edap TMS SA | 62.92M |
| Cellectis SA | 84.70M |
| Biophytis SA | -4.264M |
| Genfit SA | 75.11M |
| Adaptimmune Therapeutics PLC | 39.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.99M |
| Total Liabilities (Quarterly) | 42.80M |